By comparing sensitive vs acquired BTKi-R cells, we have defined BTKi-R as a 14q32 miRNA cluster-dependent regulation of PTEN/AKT/mTOR in CLL and DLBCL in the absence of BTK or PLCG2 mutations. This evidence concerns the gene MTOR and B-cell chronic lymphocytic leukemia.